EUVIMEDEUVIMED entdecken
Crossref

In situ pro-regenerative and repair capabilities of human umbilical mesenchymal stem cells and collagen hydrogel complex in mice with thin endometrium

Mingye Chen, Junjie Tang, Binfa Liang, Gang Feng, Zefeng Deng, Simin Chen, Qing Sun, Jie Liu, Xian Chen

Acta Biomaterialia · 2025

DOI: 10.1016/j.actbio.2025.10.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Mingye Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Reproductive Immunology for Peri-implantation, Shenzhen Zhongshan Institute for Reproductive Medicine and Genetics, Shenzh…. Hauptthemen laut MEDLINE: Endometrium, Mesenchymal Stem Cells, Hydrogels, Regeneration. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Shenzhen Science and Technology Innovation Program, Shenzhen Science and Technology Innovation Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing prevalence of refractory thin endometrium (TE) is a serious issue affecting women's reproductive health. Human umbilical cord-derived mesenchymal stem cells (huMSCs) have shown therapeutic potential for TE. However, their clinical application is limited by poor cell retention, low survival rates, and unclear regenerative mechanisms. Here, we introduced an injectable 3D delivery system using clinically applicable collagen hydrogels to encapsulate huMSCs (Gel-huMSCs), offering a promising strategy for endometrial regeneration. We systematically optimized the physicochemical properties of the collagen hydrogels to enhance their efficacy in 3D stem cell culture. Our TE mouse model demonstrated that Gel-huMSCs effectively restore uterine function by increasing endometrial thickness, reconstructing immune homeostasis, promoting angiogenesis, and reversing fibrosis. Specifically, we observed significant upregulation of tissue regeneration-related genes (Vegf, Cdh4, and Foxa2) and downregulation of inflammatory response-related genes (Mstn, Tnf, Trem1, and Col4a3) in the endometrium after Gel-huMSCs therapy compared to the control group. These findings provide insights into the regenerative mechanism of Gel-huMSCs in improving endometrial repair in TE. Notably, our study confirmed the safety of Gel-huMSCs and their efficacy in enhancing fertility rates in TE treatment. In conclusion, these results suggest that Gel-huMSCs represent a promising and viable therapeutic strategy for stem cell-based treatment of TE in clinical applications. STATEMENT OF SIGNIFICANCE: Thin endometrium (TE) is a major contributor to infertility and adverse pregnancy outcomes. Human umbilical cord-derived mesenchymal stem cells (huMSCs) have shown therapeutic potential for TE, yet their clinical translation is limited by poor retention and an incomplete understanding of their regenerative mechanisms. Here, we have developed a thermosensitive injectable type I collagen hydrogel engineered to carry huMSCs (Gel-huMSCs). The hydrogel recapitulates key physicochemical and architectural features of the native endometrial extracellular matrix, preserving huMSC stemness and augmenting proliferation and angiogenesis in vitro. An AIEgen (DPTA-BT) was employed to label and track huMSCs in vivo. After intrauterine injection, Gel-huMSCs undergo controlled enzymatic degradation, gradually releasing viable cells that integrate into the endometrial epithelium and stroma. RNA sequencing of treated endometrial tissue has demonstrated significant up-regulation of genes associated with extracellular-matrix remodeling and angiogenesis, together with down-regulation of pro-inflammatory cytokine pathways. In a validated rat model of TE, Gel-huMSCs have been shown to increase endometrial thickness and restore fertility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriumMesenchymal Stem CellsHydrogelsRegenerationMesenchymal Stem Cell TransplantationUmbilical CordCollagenFemaleAnimalsHumansMice

Stichwörter der Autor:innen

Endometrial regenerationHuman umbilical mesenchymal stem cellsHydrogelImmune cellsThin endometrium

Substanzen

HydrogelsCollagen

Autor:innen und Institutionen

  • Shenzhen Key Laboratory of Reproductive Immunology for Peri-implantation, Shenzhen Zhongshan Institute for Reproductive Medicine and Genetics, Shenzhen Zhongshan Obstetrics and Gynecology Hospital (formerly Shenzhen Zho…
  • School of Biomedical Engineering, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, China.
  • School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan, Hunan, China.
  • School of Biomedical Engineering, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, China. Electronic address: liujie56@mail.sysu.edu.cn.

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Shenzhen Science and Technology Innovation Program
  • Shenzhen Science and Technology Innovation Committee

Zitieren

APA

Chen, M., Tang, J., Liang, B., Feng, G., Deng, Z., Chen, S., Sun, Q., Liu, J., & Chen, X. (2025). In situ pro-regenerative and repair capabilities of human umbilical mesenchymal stem cells and collagen hydrogel complex in mice with thin endometrium. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2025.10.026

Vancouver

Chen M, Tang J, Liang B, Feng G, Deng Z, Chen S, et al. In situ pro-regenerative and repair capabilities of human umbilical mesenchymal stem cells and collagen hydrogel complex in mice with thin endometrium. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2025.10.026

BibTeX
@article{Chen2025,
  author = {Chen, Mingye and Tang, Junjie and Liang, Binfa and Feng, Gang and Deng, Zefeng and Chen, Simin and Sun, Qing and Liu, Jie and Chen, Xian},
  title = {In situ pro-regenerative and repair capabilities of human umbilical mesenchymal stem cells and collagen hydrogel complex in mice with thin endometrium},
  journal = {Acta Biomaterialia},
  year = {2025},
  doi = {10.1016/j.actbio.2025.10.026}
}
Kostenlos starten →